UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Replicating viral vectors as HIV vaccines: Summary report from the IAVI-sponsored satellite symposium at the AIDS vaccine 2009 conference

Biologicals, 2010-07, Vol.38 (4), p.511-521

2010

Volltextzugriff (PDF)

Modulation of macrophage-mediated tumoricidal activity by neuropeptides and neurohormones

The Journal of immunology (1950), 1985-07, Vol.135 (1), p.350-354

1985

Volltextzugriff (PDF)

Evaluation of a lipopeptide immunogen as a therapeutic in HIV type 1-seropositive individuals

AIDS research and human retroviruses, 2000-03, Vol.16 (4), p.337-343

2000

Volltextzugriff (PDF)

Replicating viral vectors as HIV vaccines Summary Report from IAVI Sponsored Satellite Symposium, International AIDS Society Conference, July 22, 2007

Biologicals, 2008-09, Vol.36 (5), p.277-286

2008

Volltextzugriff (PDF)

DNA vaccination followed by macromolecular multicomponent peptide vaccination against HIV-1 induces strong antigen-specific immunity

Vaccine, 1997-07, Vol.15 (10), p.1049-1056

1997

Volltextzugriff (PDF)

Accelerating the development of a safe and effective HIV vaccine: HIV vaccine case study for the Decade of Vaccines

Vaccine, 2013-04, Vol.31, p.B204-B208

2013

Volltextzugriff (PDF)

HIV vaccine design and the neutralizing antibody problem

Nature immunology, 2004-03, Vol.5 (3), p.233-236

2004

Volltextzugriff (PDF)

Neuroendocrine hormones suppress macrophage-mediated lysis of herpes simplex virus-infected cells

The Journal of immunology (1950), 1986-01, Vol.136 (2), p.705-709

1986

Volltextzugriff (PDF)

Viral vector delivery of Env trimer immunogens

Retrovirology, 2012-09, Vol.9 (S2), p.P341-P341, Article P341

2012

Volltextzugriff (PDF)

Recognition and penetration of the HIV-1 Env glycan shield by potent broadly neutralizing antibodies

Retrovirology, 2012-09, Vol.9 (S2), p.P48-P48, Article P48

2012

Volltextzugriff (PDF)

A short segment in the HIV-1 gp120 V1/V2 region is a major determinant of neutralization resistance to PG9-like antibodies

Retrovirology, 2012-09, Vol.9 (S2), p.O29-O29, Article O29

2012

Volltextzugriff (PDF)

Development of a vaccine for the prevention of AIDS, a critical appraisal

Vaccine, 1992, Vol.10 (14), p.1039-1052

1992

Volltextzugriff (PDF)

Future directions in HIV vaccine development

AIDS research and human retroviruses, 1992-08, Vol.8 (8), p.1313-1315

1992

Volltextzugriff (PDF)

Progress and challenges toward an AIDS vaccine : Brother, can you spare a paradigm ?

Journal of clinical immunology, 1996-05, Vol.16 (3), p.127-133

1996

Volltextzugriff (PDF)

HIV vaccine design: insights from live attenuated SIV vaccines

Nature immunology, 2006-01, Vol.7 (1), p.19-23

2006

Volltextzugriff (PDF)

A Dose-Ranging Study of a Prototype Synthetic HIV-1MN V3 Branched Peptide Vaccine

The Journal of infectious diseases, 1996-02, Vol.173 (2), p.330-339

1996

Volltextzugriff (PDF)

Postexposure Immunoprophylaxis of Primary Isolates by an Antibody to HIV Receptor Complex

Proceedings of the National Academy of Sciences - PNAS, 1999-08, Vol.96 (18), p.10367-10372

1999

Volltextzugriff (PDF)

Efficacy trials for HIV/AIDS vaccines

AIDS research and human retroviruses, 1992-08, Vol.8 (8), p.1527-1529

1992

Volltextzugriff (PDF)

Interleukin 1 release by human monocytes treated with liposome-encapsulated lipopolysaccharide

The Journal of immunology (1950), 1987-08, Vol.139 (4), p.1120-1126

1987

Volltextzugriff (PDF)

Inhibition of influenza virus uncoating by rimantadine hydrochloride

Journal of Virology, 1979-07, Vol.31 (1), p.261-263

1979

Volltextzugriff (PDF)

Human trials of AIDS vaccines: current status and future directions

AIDS (London), 1989, Vol.3 Suppl 1 (Supplement), p.S125-130

1989

Volltextzugriff (PDF)

The Next Steps Toward a Global AIDS Vaccine

Science (American Association for the Advancement of Science), 1994-11, Vol.266 (5189), p.1335-1337

Koff, Wayne C.

1994

Volltextzugriff (PDF)

Human Monocytes Activated by Immunomodulators in Liposomes Lyse Herpesvirus-Infected but not Normal Cells

Science (American Association for the Advancement of Science), 1984-06, Vol.224 (4652), p.1007-1009

1984

Volltextzugriff (PDF)

Vaccination of Vaccinia-Naive Adults with Human Immunodeficiency Virus Type 1 gp160 Recombinant Vaccinia Virus in a Blinded, Controlled, Randomized Clinical Trial

The Journal of infectious diseases, 1992-08, Vol.166 (2), p.244-252

1992

Volltextzugriff (PDF)

Lysis of herpesvirus-infected cells by macrophages activated with free or liposome-encapsulated lymphokine produced by a murine T cell hybridoma

Infection and Immunity, 1983-12, Vol.42 (3), p.1067-1072

1983

Volltextzugriff (PDF)

1 – 25 von 191

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(182)
Mit Volltextzugriff
(159)

Publikationsform

Sprache

Englisch
(191)

Erscheinungsjahr

n.n

Thema

Science & Technology
(120)
Life Sciences & Biomedicine
(89)
Humans
(85)
Biological And Medical Sciences
(49)
Animals
(46)
Immunology
(37)
Male
(36)
Medical Sciences
(29)
Female
(27)
Microbiology
(25)
Fundamental And Applied Biological Sciences. Psychology
(23)
Mice
(23)
Adult
(22)
Vaccines
(22)
Aids/hiv
(21)
Physical Sciences
(20)
Virology
(19)
Astronomy & Astrophysics
(18)
Hiv
(18)
Hiv-1 - Immunology
(18)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Replicating viral vectors as HIV vaccines: Summary report from the IAVI-sponsored satellite symposium at the AIDS vaccine 2009 conference

Modulation of macrophage-mediated tumoricidal activity by neuropeptides and neurohormones

Evaluation of a lipopeptide immunogen as a therapeutic in HIV type 1-seropositive individuals

Replicating viral vectors as HIV vaccines Summary Report from IAVI Sponsored Satellite Symposium, International AIDS Society Conference, July 22, 2007

DNA vaccination followed by macromolecular multicomponent peptide vaccination against HIV-1 induces strong antigen-specific immunity

Accelerating the development of a safe and effective HIV vaccine: HIV vaccine case study for the Decade of Vaccines

HIV vaccine design and the neutralizing antibody problem

Neuroendocrine hormones suppress macrophage-mediated lysis of herpes simplex virus-infected cells

Viral vector delivery of Env trimer immunogens

Recognition and penetration of the HIV-1 Env glycan shield by potent broadly neutralizing antibodies

A short segment in the HIV-1 gp120 V1/V2 region is a major determinant of neutralization resistance to PG9-like antibodies

Development of a vaccine for the prevention of AIDS, a critical appraisal

Future directions in HIV vaccine development

Progress and challenges toward an AIDS vaccine : Brother, can you spare a paradigm ?

HIV vaccine design: insights from live attenuated SIV vaccines

A Dose-Ranging Study of a Prototype Synthetic HIV-1MN V3 Branched Peptide Vaccine

Postexposure Immunoprophylaxis of Primary Isolates by an Antibody to HIV Receptor Complex

Efficacy trials for HIV/AIDS vaccines

Interleukin 1 release by human monocytes treated with liposome-encapsulated lipopolysaccharide

Inhibition of influenza virus uncoating by rimantadine hydrochloride

Human trials of AIDS vaccines: current status and future directions

The Next Steps Toward a Global AIDS Vaccine

Human Monocytes Activated by Immunomodulators in Liposomes Lyse Herpesvirus-Infected but not Normal Cells

Vaccination of Vaccinia-Naive Adults with Human Immunodeficiency Virus Type 1 gp160 Recombinant Vaccinia Virus in a Blinded, Controlled, Randomized Clinical Trial

Lysis of herpesvirus-infected cells by macrophages activated with free or liposome-encapsulated lymphokine produced by a murine T cell hybridoma

Suchergebnisse filtern